BCYC FY 2017 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena

BCYCBicycle Therapeutics plc

$360M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M

Gross Profit

-$10M-476.0% margin

Operating Income

-$16M-787.0% margin

Net Income

-$16M-789.3% margin

EPS (Diluted)

$-1.22

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$3M

Stock-Based Comp.

$515,000

Balance Sheet

Total Assets

$74M

Total Liabilities

$121M

Stockholders' Equity

-$47M

Cash & Equivalents

$68M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$0	—
Gross Profit	-$10M	-$269,289	-3541.4%
Operating Income	-$16M	-$13M	-20.2%
Net Income	-$16M	-$14M	-20.3%